FLT3LG: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})) |
imported>Rjwilmsi m (→top: Journal cites: tidy pubmed URL, added 1 PMID, added 1 PMC) |
||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
< | {{Infobox_gene}} | ||
{{ | '''Fms-related tyrosine kinase 3 ligand''' ('''FLT3LG''') is a [[protein]] which in humans is encoded by the ''FLT3LG'' [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: FLT3LG fms-related tyrosine kinase 3 ligand| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2323| accessdate = }}</ref><ref name="pmid8145851">{{cite journal |vauthors=Hannum C, Culpepper J, Campbell D, McClanahan T, Zurawski S, Bazan JF, Kastelein R, Hudak S, Wagner J, Mattson J | title = Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs | journal = Nature | volume = 368 | issue = 6472 | pages = 643–8 |date=April 1994 | pmid = 8145851 | doi = 10.1038/368643a0 | url = }}</ref><ref name="pmid7824267">{{cite journal |vauthors=Lyman SD, James L, Escobar S, Downey H, de Vries P, Brasel K, Stocking K, Beckmann MP, Copeland NG, Cleveland LS | title = Identification of soluble and membrane-bound isoforms of the murine flt3 ligand generated by alternative splicing of mRNAs | journal = Oncogene | volume = 10 | issue = 1 | pages = 149–57 |date=January 1995 | pmid = 7824267 | doi = | url = }}</ref> | ||
| | |||
| | |||
| | |||
| | |||
| | |||
}} | |||
Flt3 ligand (FL) is a [[haematopoiesis|hematopoietic]] four helical bundle [[cytokine]]. It is structurally homologous to [[stem cell factor]] (SCF) and colony stimulating factor 1 ([[Macrophage colony-stimulating factor|CSF-1]]). In synergy with other growth factors, Flt3 ligand stimulates the proliferation and differentiation of various blood cell [[progenitor cell|progenitors]]. For example, it is a major growth factor stimulating the growth of [[dendritic cells]].<ref>{{cite journal|last1=Harsuncky|first1=H|title=Flt3 Ligand Regulates Dendritic Cell Development from Flt3+ Lymphoid and Myeloid-committed Progenitors to Flt3+ Dendritic Cells In Vivo|journal=J Exp Med|date=Jul 21, 2003|doi=10.1084/jem.20030323|pmc=2194067|pmid=12874263|volume=198|pages=305–13}}</ref> | |||
==References== | |||
{{ | {{reflist}} | ||
}} | |||
==Further reading== | ==Further reading== | ||
{{refbegin | 2}} | {{refbegin | 2}} | ||
{{PBB_Further_reading | {{PBB_Further_reading | ||
| citations = | | citations = | ||
*{{cite journal | author=Lyman SD | *{{cite journal | author=Lyman SD |title=Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells |journal=Cell |volume=75 |issue= 6 |pages= 1157–67 |year= 1994 |pmid= 7505204 |doi=10.1016/0092-8674(93)90325-K |name-list-format=vanc| author2=James L | author3=Vanden Bos T | display-authors=3 | last4=De Vries | first4=Peter | last5=Brasel | first5=Ken | last6=Gliniak | first6=Brian | last7=Hollingsworth | first7=L.T. | last8=Picha | first8=Kathleen S. | last9=McKenna | first9=Hilary J. }} | ||
*{{cite journal | author=Lyman SD |title=Structural analysis of human and murine flt3 ligand genomic loci |journal=Oncogene |volume=11 |issue= 6 |pages= 1165–72 |year= 1995 |pmid= 7566977 |doi= |name-list-format=vanc| author2=Stocking K | author3=Davison B | display-authors=3 | last4=Fletcher | first4=F | last5=Johnson | first5=L | last6=Escobar | first6=S }} | |||
*{{cite journal | author=Lyman SD | *{{cite journal | author=Lyman SD |title=Identification of soluble and membrane-bound isoforms of the murine flt3 ligand generated by alternative splicing of mRNAs |journal=Oncogene |volume=10 |issue= 1 |pages= 149–57 |year= 1995 |pmid= 7824267 |doi= |name-list-format=vanc| author2=James L | author3=Escobar S | display-authors=3 | last4=Downey | first4=H | last5=De Vries | first5=P | last6=Brasel | first6=K | last7=Stocking | first7=K | last8=Beckmann | first8=MP | last9=Copeland | first9=NG }} | ||
*{{cite journal | author=Hannum C |title=Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs |journal=Nature |volume=368 |issue= 6472 |pages= 643–8 |year= 1994 |pmid= 8145851 |doi= 10.1038/368643a0 |name-list-format=vanc| author2=Culpepper J | author3=Campbell D | display-authors=3 | last4=McClanahan | first4=T. | last5=Zurawski | first5=S. | last6=Kastelein | first6=R. | last7=Bazan | first7=J. F. | last8=Hudak | first8=S. | last9=Wagner | first9=J. }} | |||
*{{cite journal | author=Lyman SD | *{{cite journal | author=Lyman SD |title=Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells |journal=Blood |volume=83 |issue= 10 |pages= 2795–801 |year= 1994 |pmid= 8180375 |doi= |name-list-format=vanc| author2=James L | author3=Johnson L | display-authors=3 | last4=Brasel | first4=K | last5=De Vries | first5=P | last6=Escobar | first6=SS | last7=Downey | first7=H | last8=Splett | first8=RR | last9=Beckmann | first9=MP }} | ||
*{{cite journal | author=Slanicka Krieger M |title=The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow |journal=Exp. Hematol. |volume=26 |issue= 5 |pages= 365–73 |year= 1998 |pmid= 9590652 |doi= |name-list-format=vanc| author2=Nissen C | author3=Manz CY | display-authors=3 | last4=Toksoz | first4=D | last5=Lyman | first5=SD | last6=Wodnar-Filipowicz | first6=A }} | |||
*{{cite journal | author= | *{{cite journal | author=Graddis TJ |title=Structure-function analysis of FLT3 ligand-FLT3 receptor interactions using a rapid functional screen |journal=J. Biol. Chem. |volume=273 |issue= 28 |pages= 17626–33 |year= 1998 |pmid= 9651358 |doi=10.1074/jbc.273.28.17626 |name-list-format=vanc| author2=Brasel K | author3=Friend D | display-authors=3 | last4=Srinivasan | first4=S | last5=Wee | first5=S | last6=Lyman | first6=SD | last7=March | first7=CJ | last8=McGrew | first8=JT }} | ||
*{{cite journal | author=Solanilla A |title=Expression of Flt3-ligand by the endothelial cell |journal=Leukemia |volume=14 |issue= 1 |pages= 153–62 |year= 2000 |pmid= 10637491 |doi=10.1038/sj.leu.2401635 |name-list-format=vanc| author2=Grosset C | author3=Lemercier C | display-authors=3 | last4=Dupouy | first4=M | last5=Mahon | first5=F X | last6=Schweitzer | first6=K | last7=Reiffers | first7=J | last8=Weksler | first8=B | last9=Ripoche | first9=J }} | |||
*{{cite journal |author1=Savvides SN |author2=Boone T |author3=Karplus P.A. |title=Flt3 ligand structure and unexpected commonalities of helical bundles and cystine knots |journal=Nat. Struct. Biol. |volume=7 |issue= 6 |pages= 486–91 |year= 2000 |pmid= 10881197 |doi= 10.1038/75896 }} | |||
*{{cite journal | author= | *{{cite journal | author=Chklovskaia E |title=Cell-surface trafficking and release of flt3 ligand from T lymphocytes is induced by common cytokine receptor gamma-chain signaling and inhibited by cyclosporin A |journal=Blood |volume=97 |issue= 4 |pages= 1027–34 |year= 2001 |pmid= 11159533 |doi=10.1182/blood.V97.4.1027 |name-list-format=vanc| author2=Nissen C | author3=Landmann L | display-authors=3 | last4=Rahner | first4=C | last5=Pfister | first5=O | last6=Wodnar-Filipowicz | first6=A }} | ||
*{{cite journal |vauthors=Agrawal DK, Hopfenspirger MT, Chavez J, Talmadge JE |title=Flt3 ligand: a novel cytokine prevents allergic asthma in a mouse model |journal=Int. Immunopharmacol. |volume=1 |issue= 12 |pages= 2081–9 |year= 2002 |pmid= 11710537 |doi=10.1016/S1567-5769(01)00122-9 }} | |||
*{{cite journal | author= | *{{cite journal |vauthors=Li H, Cai Y, Xu J |title=[Localization of a FLT3 ligand isoform in human tissues] |journal=Zhonghua Xue Ye Xue Za Zhi |volume=20 |issue= 6 |pages= 285–7 |year= 2002 |pmid= 11721383 |doi= }} | ||
*{{cite journal | author=Feugier P |title=Ex vivo expansion of stem and progenitor cells in co-culture of mobilized peripheral blood CD34+ cells on human endothelium transfected with adenovectors expressing thrombopoietin, c-kit ligand, and Flt-3 ligand |journal=J. Hematother. Stem Cell Res. |volume=11 |issue= 1 |pages= 127–38 |year= 2003 |pmid= 11847009 |doi= 10.1089/152581602753448595 |name-list-format=vanc| author2=Jo DY | author3=Shieh JH | display-authors=3 | last4=MacKenzie | first4=Karen L. | last5=Rafii | first5=Shahin | last6=Crystal | first6=Ronald G. | last7=Moore | first7=Malcolm A.S. }} | |||
*{{cite journal | author=O'Keeffe M |title=Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice |journal=Blood |volume=99 |issue= 6 |pages= 2122–30 |year= 2002 |pmid= 11877288 |doi=10.1182/blood.V99.6.2122 |name-list-format=vanc| author2=Hochrein H | author3=Vremec D | display-authors=3 | last4=Pooley | first4=J | last5=Evans | first5=R | last6=Woulfe | first6=S | last7=Shortman | first7=K }} | |||
*{{cite journal | author= | *{{cite journal | author=Retzlaff S |title=Interleukin 8 and Flt3 ligand as markers of advanced disease in primary gastrointestinal non-Hodgkin's lymphoma |journal=Oncol. Rep. |volume=9 |issue= 3 |pages= 525–7 |year= 2002 |pmid= 11956621 |doi= 10.3892/or.9.3.525|name-list-format=vanc| author2=Padró T | author3=Koch P | display-authors=3 | last4=Oelmann | first4=E | last5=Lügering | first5=N | last6=Mesters | first6=RM | last7=Berdel | first7=WE }} | ||
*{{cite journal | author=Sigurjónsson OE |title=Flt3/Flk-2-ligand in synergy with thrombopoietin delays megakaryocyte development and increases the numbers of megakaryocyte progenitor cells in serum-free cultures initiated with CD34+ cells |journal=J. Hematother. Stem Cell Res. |volume=11 |issue= 2 |pages= 389–400 |year= 2003 |pmid= 11983110 |doi= 10.1089/152581602753658574 |name-list-format=vanc| author2=Gudmundsson KO | author3=Haraldsdóttir V | display-authors=3 | last4=Rafnar | first4=Thorunn | last5=Gudmundsson | first5=Sveinn }} | |||
*{{cite journal | | *{{cite journal | author=Vávrová J |title=Antiapoptotic cytokine IL-3 + SCF + FLT3L influence on proliferation of gamma-irradiated AC133+/CD34+ progenitor cells |journal=Folia Biol. (Praha) |volume=48 |issue= 2 |pages= 51–7 |year= 2002 |pmid= 12002675 |doi= |name-list-format=vanc| author2=Vokurková D | author3=Mareková M | display-authors=3 | last4=Bláha | first4=M | last5=Jebavý | first5=L | last6=Filip | first6=S }} | ||
*{{cite journal | author= | *{{cite journal | author=Testa U |title=Human acute stem cell leukemia with multilineage differentiation potential via cascade activation of growth factor receptors |journal=Blood |volume=99 |issue= 12 |pages= 4634–7 |year= 2002 |pmid= 12036900 |doi=10.1182/blood.V99.12.4634 |name-list-format=vanc| author2=Torelli GF | author3=Riccioni R | display-authors=3 | last4=Muta | first4=AO | last5=Militi | first5=S | last6=Annino | first6=L | last7=Mariani | first7=G | last8=Guarini | first8=A | last9=Chiaretti | first9=S }} | ||
*{{cite journal | author=Mosca PJ |title=Multiple signals are required for maturation of human dendritic cells mobilized in vivo with Flt3 ligand |journal=J. Leukoc. Biol. |volume=72 |issue= 3 |pages= 546–53 |year= 2002 |pmid= 12223523 |doi= |name-list-format=vanc| author2=Hobeika AC | author3=Colling K | display-authors=3 | last4=Clay | first4=TM | last5=Thomas | first5=EK | last6=Caron | first6=D | last7=Lyerly | first7=HK | last8=Morse | first8=MA }} | |||
*{{cite journal | | *{{cite journal | author=Strausberg RL |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 |name-list-format=vanc| author2=Feingold EA | author3=Grouse LH | display-authors=3 | last4=Derge | first4=JG | last5=Klausner | first5=RD | last6=Collins | first6=FS | last7=Wagner | first7=L | last8=Shenmen | first8=CM | last9=Schuler | first9=GD }} | ||
}} | }} | ||
{{refend}} | {{refend}} | ||
{{PDB Gallery|geneid=2323}} | |||
{{ | {{Regulome | ||
{{ | | activates = [[MAP kinase]], [[FLT3]], [[STAT5A]] | ||
| inhibits = [[tyrosine kinase]], PSA | |||
| activated_by = | |||
| inhibited_by = | |||
}} | |||
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. --> | |||
{{PBB_Controls | |||
| update_page = yes | |||
| require_manual_inspection = no | |||
| update_protein_box = yes | |||
| update_summary = no | |||
| update_citations = yes | |||
}} |
Latest revision as of 12:02, 12 March 2018
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
Fms-related tyrosine kinase 3 ligand (FLT3LG) is a protein which in humans is encoded by the FLT3LG gene.[1][2][3]
Flt3 ligand (FL) is a hematopoietic four helical bundle cytokine. It is structurally homologous to stem cell factor (SCF) and colony stimulating factor 1 (CSF-1). In synergy with other growth factors, Flt3 ligand stimulates the proliferation and differentiation of various blood cell progenitors. For example, it is a major growth factor stimulating the growth of dendritic cells.[4]
References
- ↑ "Entrez Gene: FLT3LG fms-related tyrosine kinase 3 ligand".
- ↑ Hannum C, Culpepper J, Campbell D, McClanahan T, Zurawski S, Bazan JF, Kastelein R, Hudak S, Wagner J, Mattson J (April 1994). "Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs". Nature. 368 (6472): 643–8. doi:10.1038/368643a0. PMID 8145851.
- ↑ Lyman SD, James L, Escobar S, Downey H, de Vries P, Brasel K, Stocking K, Beckmann MP, Copeland NG, Cleveland LS (January 1995). "Identification of soluble and membrane-bound isoforms of the murine flt3 ligand generated by alternative splicing of mRNAs". Oncogene. 10 (1): 149–57. PMID 7824267.
- ↑ Harsuncky, H (Jul 21, 2003). "Flt3 Ligand Regulates Dendritic Cell Development from Flt3+ Lymphoid and Myeloid-committed Progenitors to Flt3+ Dendritic Cells In Vivo". J Exp Med. 198: 305–13. doi:10.1084/jem.20030323. PMC 2194067. PMID 12874263.
Further reading
- Lyman SD, James L, Vanden Bos T, et al. (1994). "Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells". Cell. 75 (6): 1157–67. doi:10.1016/0092-8674(93)90325-K. PMID 7505204.
- Lyman SD, Stocking K, Davison B, et al. (1995). "Structural analysis of human and murine flt3 ligand genomic loci". Oncogene. 11 (6): 1165–72. PMID 7566977.
- Lyman SD, James L, Escobar S, et al. (1995). "Identification of soluble and membrane-bound isoforms of the murine flt3 ligand generated by alternative splicing of mRNAs". Oncogene. 10 (1): 149–57. PMID 7824267.
- Hannum C, Culpepper J, Campbell D, et al. (1994). "Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs". Nature. 368 (6472): 643–8. doi:10.1038/368643a0. PMID 8145851.
- Lyman SD, James L, Johnson L, et al. (1994). "Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells". Blood. 83 (10): 2795–801. PMID 8180375.
- Slanicka Krieger M, Nissen C, Manz CY, et al. (1998). "The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow". Exp. Hematol. 26 (5): 365–73. PMID 9590652.
- Graddis TJ, Brasel K, Friend D, et al. (1998). "Structure-function analysis of FLT3 ligand-FLT3 receptor interactions using a rapid functional screen". J. Biol. Chem. 273 (28): 17626–33. doi:10.1074/jbc.273.28.17626. PMID 9651358.
- Solanilla A, Grosset C, Lemercier C, et al. (2000). "Expression of Flt3-ligand by the endothelial cell". Leukemia. 14 (1): 153–62. doi:10.1038/sj.leu.2401635. PMID 10637491.
- Savvides SN; Boone T; Karplus P.A. (2000). "Flt3 ligand structure and unexpected commonalities of helical bundles and cystine knots". Nat. Struct. Biol. 7 (6): 486–91. doi:10.1038/75896. PMID 10881197.
- Chklovskaia E, Nissen C, Landmann L, et al. (2001). "Cell-surface trafficking and release of flt3 ligand from T lymphocytes is induced by common cytokine receptor gamma-chain signaling and inhibited by cyclosporin A". Blood. 97 (4): 1027–34. doi:10.1182/blood.V97.4.1027. PMID 11159533.
- Agrawal DK, Hopfenspirger MT, Chavez J, Talmadge JE (2002). "Flt3 ligand: a novel cytokine prevents allergic asthma in a mouse model". Int. Immunopharmacol. 1 (12): 2081–9. doi:10.1016/S1567-5769(01)00122-9. PMID 11710537.
- Li H, Cai Y, Xu J (2002). "[Localization of a FLT3 ligand isoform in human tissues]". Zhonghua Xue Ye Xue Za Zhi. 20 (6): 285–7. PMID 11721383.
- Feugier P, Jo DY, Shieh JH, et al. (2003). "Ex vivo expansion of stem and progenitor cells in co-culture of mobilized peripheral blood CD34+ cells on human endothelium transfected with adenovectors expressing thrombopoietin, c-kit ligand, and Flt-3 ligand". J. Hematother. Stem Cell Res. 11 (1): 127–38. doi:10.1089/152581602753448595. PMID 11847009.
- O'Keeffe M, Hochrein H, Vremec D, et al. (2002). "Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice". Blood. 99 (6): 2122–30. doi:10.1182/blood.V99.6.2122. PMID 11877288.
- Retzlaff S, Padró T, Koch P, et al. (2002). "Interleukin 8 and Flt3 ligand as markers of advanced disease in primary gastrointestinal non-Hodgkin's lymphoma". Oncol. Rep. 9 (3): 525–7. doi:10.3892/or.9.3.525. PMID 11956621.
- Sigurjónsson OE, Gudmundsson KO, Haraldsdóttir V, et al. (2003). "Flt3/Flk-2-ligand in synergy with thrombopoietin delays megakaryocyte development and increases the numbers of megakaryocyte progenitor cells in serum-free cultures initiated with CD34+ cells". J. Hematother. Stem Cell Res. 11 (2): 389–400. doi:10.1089/152581602753658574. PMID 11983110.
- Vávrová J, Vokurková D, Mareková M, et al. (2002). "Antiapoptotic cytokine IL-3 + SCF + FLT3L influence on proliferation of gamma-irradiated AC133+/CD34+ progenitor cells". Folia Biol. (Praha). 48 (2): 51–7. PMID 12002675.
- Testa U, Torelli GF, Riccioni R, et al. (2002). "Human acute stem cell leukemia with multilineage differentiation potential via cascade activation of growth factor receptors". Blood. 99 (12): 4634–7. doi:10.1182/blood.V99.12.4634. PMID 12036900.
- Mosca PJ, Hobeika AC, Colling K, et al. (2002). "Multiple signals are required for maturation of human dendritic cells mobilized in vivo with Flt3 ligand". J. Leukoc. Biol. 72 (3): 546–53. PMID 12223523.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.